InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,857.17
(
-0.59%
)
Post# of 364056
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

jimmybob

Send PM Follow Ignore
Followers 1880
Posts 137645
Boards Moderated 5
Alias Born 01/03/2007

jimmybob

Re: None

Wednesday, 03/21/2018 5:41:14 AM

Wednesday, March 21, 2018 5:41:14 AM

Post# of 364056
Celgene reinstated with an Overweight at JPMorgan
JPMorgan analyst Cory Kasimov reinstated coverage with an Overweight rating and $110 price target. Before moving to a not rated designation the analyst had an Overweight rating on the shares. Kasimov continues to believe Celgene's valuation is "too compelling to ignore." He sees the company's "deep and broad pipeline" driving industry-leading growth through 2022

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up